News & Events
-
August 30, 2015
Critical Path Institute’s Polycystic Kidney Disease Outcomes Consortium Secures FDA Qualification for Enrichment Biomarker in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
August 31, 2015 Critical Path Institute’s Polycystic Kidney Disease Outcomes Consortium Secures FDA Qualification for Enrichment Biomarker in Autosomal Dominant Polycystic Kidney Disease (ADPKD) TUCSON, Ariz., August 31, 2015 – The Critical Path Institute (C-Path) announced today that the U.S. Food and Drug Administration (FDA) has issued a qualification decision in the form of a... - August 21, 2015
-
August 19, 2015
AZBio Honors Lynn Hudson, Ph.D. Of Critical Path Institute As 2015 Arizona Bioscience Leader
August 19, 2015 AZBio Honors Lynn Hudson, Ph.D. Of Critical Path Institute As 2015 Arizona Bioscience Leader August 19, 2015 – Citing her leadership in advancing extremely complex biomedical research, the Arizona BioIndustry Association today announced that Lynn Hudson, Ph.D., Chief Science Officer for the Critical Path Institute, will be honored with the Jon W.... - August 17, 2015
-
August 17, 2015
New Clinical Infectious Diseases Journal Supplement Highlights Hollow Fiber System Model for Tuberculosis
New Clinical Infectious Diseases Journal Supplement Highlights Hollow Fiber System Model for Tuberculosis The achievements and ongoing efforts of C-Path’s Critical Path to TB Drug Regimens (CPTR) initiative’s work on the Hollow Fiber System Model for Tuberculosis (HFS-TB) are detailed in a new supplement published in the Clinical Infectious Diseases journal. The supplement includes...
